Streptomyces species are soil-dwelling bacteria that produce vast numbers of pharmaceutically valuable secondary metabolites (SMs), such as antibiotics, immunosuppressants, antiviral, and anticancer drugs. On the other hand, the biosynthesis of most SMs remains very low due to tightly controlled regulatory networks. Both global and pathway-specific regulators are involved in the regulation of a specific SM biosynthesis in various Streptomyces species. Over the past few decades, many of these regulators have been identified and new ones are still being discovered. Among them, a global regulator of SM biosynthesis named WblA was identified in several Streptomyces species. The identification and understanding of the WblAs have greatly contributed to increasing the productivity of several Streptomyces SMs. This review summarizes the characteristics and applications on WblAs reported to date, which were found in various Streptomyces species and other actinobacteria.
CITATION STYLE
Nah, H. J., Park, J., Choi, S., & Kim, E. S. (2021). WblA, a global regulator of antibiotic biosynthesis in Streptomyces. Journal of Industrial Microbiology and Biotechnology, 48(3–4). https://doi.org/10.1093/jimb/kuab007
Mendeley helps you to discover research relevant for your work.